Note: Ingredients listed on restricted chemical lists
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
0.01 - 0.05
General Information
Revision date
2023-02-09
Product name
HERPES SIMPLEX 1+2 VIRCLIA IgG MONOTEST
Product name
HERPES SIMPLEX 1+2 VIRCLIA IgG MONOTEST
Identification on the label/Trade name
VIRCLIA KIT (VIRCLIA HERPES SIMPLEX 1+2 IgG MONODOSE)
1.2.1 Relevant identified uses
Industrial/Professional use specifications
Icons in SDS
Company Information
company name
VIRCELL, S.L
e-mail address of the competent person responsible for the Safety Data Sheet
customerservice@vircell.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07: Health hazard/Hazardous to the ozone layer.
Signal word
Warning.
Hazardous Ingredients
2-Methyl-2H-isothiazol-3-one.
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P302+P352 - If on skin: Wash with plenty of water. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention.
Other hazards which do not result in classification
Reagents should be considered as potentially infectious and handled accordingly. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII. This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII. The mixture does not contain PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation, category 1 H317 Full text of H statements : see section 16. Adverse physicochemical, human health and environmental effects No additional information available.
